drugset / Trial / NCT01639261
A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT
NaSingle-groupOpen-labelTreatment
Summary
Improvement of quality of life in patients with BO and establishment of a new third line therapy
Timeline
- Start
- 2012-07
- Primary completion
- 2013-12
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon gamma-1b | Protein / enzyme biologic | 50 ug/m2 | Subcutaneous |